Two new studies reveal that cost-restraints can keep patients from accessing life-preserving cancer drugs.
Managed Healthcare Executive – Health Management
Tag Archives: costly
Four ways health execs can prep for costly CAR-T cell therapies
With the high efficacy and dire diagnosis, there will be demand for both Kymriah and Yescarta. Here’s how to manage the monetary impact.
Managed Healthcare Executive – Health Management